Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio
Abstract
Authors
B. Ultsch F. Weidemann T. Reinhold A. Siedler G. Krause O. Wichmann
B. Ultsch F. Weidemann T. Reinhold A. Siedler G. Krause O. Wichmann
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now